We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+21.72%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$272M
AUM Growth
+$46.5M
Cap. Flow
+$9.18M
Cap. Flow %
3.37%
Top 10 Hldgs %
26.6%
Holding
346
New
62
Increased
72
Reduced
60
Closed
95

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$5.92M
2
SPGI icon
S&P Global
SPGI
+$4.98M
3
AMZN icon
Amazon
AMZN
+$4.9M
4
CAH icon
Cardinal Health
CAH
+$4.73M
5
CHE icon
Chemed
CHE
+$4.63M

Sector Composition

Rank Sector Weight
1 Technology 23.4%
2 Healthcare 18.72%
3 Financials 12.56%
4 Consumer Staples 11.35%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNRC icon
176
Generac Holdings
GNRC
$12.5B
$144K 0.05%
+1,256
New +$132K
SMG icon
177
ScottsMiracle-Gro
SMG
$3.66B
$144K 0.05%
+1,078
New +$139K
UNP icon
178
Union Pacific
UNP
$174B
$143K 0.05%
838
+437
+109% +$70K
TTC icon
179
Toro Company
TTC
$9.49B
$140K 0.05%
2,078
RMBS icon
180
Rambus
RMBS
$11B
$139K 0.05%
+8,968
New +$126K
FIT
181
DELISTED
Fitbit, Inc. Class A common stock
FIT
$137K 0.05%
+21,682
New +$142K
AMT icon
182
American Tower
AMT
$80.4B
$131K 0.05%
496
KLIC icon
183
Kulicke & Soffa
KLIC
$4.78B
$124K 0.05%
+5,309
New +$120K
WTRG icon
184
Essential Utilities
WTRG
$11.4B
$122K 0.04%
+2,783
New +$118K
IWM icon
185
iShares Russell 2000 ETF
IWM
$81.9B
$114K 0.04%
787
-42
-5% -$5.51K
BKH icon
186
Black Hills Corp
BKH
$5.69B
$112K 0.04%
1,919
MANT
187
DELISTED
Mantech International Corp
MANT
$109K 0.04%
+1,520
New +$112K
CVX icon
188
Chevron
CVX
$366B
$103K 0.04%
1,100
NVDA icon
189
NVIDIA
NVDA
$5.42T
$99K 0.04%
10,920
-1,800
-14% -$14.6K
SCHM icon
190
Schwab US Mid-Cap ETF
SCHM
$15.1B
$89K 0.03%
4,959
-687
-12% -$11.2K
NICE icon
191
Nice
NICE
$5.97B
$88K 0.03%
455
-35
-7% -$6.13K
GSK icon
192
GSK
GSK
$106B
$74K 0.03%
1,439
-28
-2% -$1.44K
CP icon
193
Canadian Pacific Kansas City
CP
$80.5B
$71K 0.03%
1,375
-35
-2% -$1.66K
AZN icon
194
AstraZeneca
AZN
$250B
$69K 0.03%
640
-17
-3% -$1.76K
BN icon
195
Brookfield
BN
$108B
$61K 0.02%
3,307
-508
-13% -$8.93K
PHG icon
196
Philips
PHG
$26.1B
$55K 0.02%
1,450
-70
-5% -$2.44K
IVW icon
197
iShares S&P 500 Growth ETF
IVW
$77.6B
$54K 0.02%
1,040
-120
-10% -$5.75K
BX icon
198
Blackstone
BX
$110B
$50K 0.02%
862
-800
-48% -$42.1K
SAP icon
199
SAP
SAP
$238B
$50K 0.02%
+376
New +$46.3K
BIDU icon
200
Baidu
BIDU
$37.2B
$48K 0.02%
+394
New +$42.1K

Similar funds

Contravisory Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, Contravisory Investment Management held 346 positions worth $272M, up 21% from $226M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Contravisory Investment Management deployed $9.18M of net new capital in Q2 2020, opening 62 new positions and adding to 72 existing holdings. Its largest new stake was Cardinal Health: 91,819 shares worth $5M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Walt Disney, an estimated $3.62M trimmed.

  • Contravisory Investment Management's largest Q2 2020 buy was Cardinal Health: 91,819 shares worth $5M.
  • Contravisory Investment Management added most to AbbVie in Q2 2020, an estimated $5.92M increase.
  • Contravisory Investment Management's biggest Q2 2020 reduction was Walt Disney, cutting an estimated $3.62M.
  • Contravisory Investment Management fully exited Cintas in Q2 2020, selling an estimated $6.44M.
  • Contravisory Investment Management's ten largest holdings make up 27% of its $272M portfolio in Q2 2020.
  • Contravisory Investment Management opened 62 new positions and closed 95 in Q2 2020.
  • Contravisory Investment Management's portfolio value rose 21% quarter-over-quarter to $272M.

Based on Contravisory Investment Management's 13F filing for Q2 2020, filed 9 Jul 2020.